A carregar...
The interplay between cholesterol (and other metabolic conditions) and immune-checkpoint immunotherapy: shifting the concept from the “inflamed tumor” to the “inflamed patient”
The predictive ability of metabolic conditions, such as hypercholesterolemia, on the outcome of cancer patients to immune-checkpoint inhibitors (ICIs) therapy, has been recently explored. The reasons for their value in this setting are to be searched in the individual himself more than in his tumor,...
Na minha lista:
| Publicado no: | Hum Vaccin Immunother |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8189053/ https://ncbi.nlm.nih.gov/pubmed/33427023 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2020.1852872 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|